Octagon Capital Advisors LP has filed its 13F form on May 16, 2025 for Q1 2025 where it was disclosed a total value porftolio of $301 Million distributed in 35 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Apellis Pharmaceuticals, Inc. with a value of $45.8M, Trevi Therapeutics, Inc. with a value of $20.9M, Centessa Pharmaceuticals PLC with a value of $20.5M, Gossamer Bio, Inc. with a value of $20.2M, and Ocular Therapeutix, Inc with a value of $17.8M.
Examining the 13F form we can see an decrease of $666M in the current position value, from $967M to 301M.
Octagon Capital Advisors LP is based out at New York, NY
Below you can find more details about Octagon Capital Advisors LP portfolio as well as his latest detailed transactions.
